Hypertension is common in adults aged 60 years or older. Apart from age, hypertension is
the most powerful predictor of cardiovascular end‐organ damage and its associated …

Cites a study of the European Trial on isolated systolic hypertension (ISH) in the elderly,
published in the'Journal of Human Hypertension.'Relation of systolic blood pressure and …

In all actual clinical guidelines, dihydropyridine calcium channel blockers (CCBs) belong to
the recommended first line antihypertensive drugs to treat essential hypertension. Several …

The clinical safety of lacidipine, a new dihydropyridine calcium antagonist, has been
assessed in a longterm, comparative study in hypertensive patients. Slowrelease (SR) …

Background The aim of the Nordic Diltiazem (NORDIL) Study was to compare patients with
essential hypertension receiving calcium-antagonist-based treatment with diltiazem and …

Hypertension remains the most prevalent and preventable cause of cardiovascular (CHD)
and cerebrovascular (CVD) disease, and there is good evidence that antihypertensive drugs …

The symposium 'Current perspective on the use of calcium channel blockers in the treatment
of hypertensive patients', held in Stresa (Italy) on 28th and 29th June 2018 with the …

Calcium antagonists (CAs), as a class, have to date not been properly evaluated in order to
determine their long-term efficacy and safety in the treatment of hypertension. Small short …

NORDIL-the Nordic diltiazem intervention study was started in September 1992. This trial is
a prospective randomized open blinded-endpoint (PROBE) multicenter, parallel-group study …

Objectives To evaluate and correlate the effects of long-term antihypertensive treatment on
left ventricular (LV) mass and carotid structural changes in a large group of essential …